A Phase 1 Safety and PK Study of IV TP-271

NCT03234738 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: TP-271
DRUG: Placebo

Sponsor

Tetraphase Pharmaceuticals, Inc

Collaborators

[object Object]